NORMA PICHARDO: Open Payments
NPI 1922479146 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,053 in 22 payments from 8 companies in 2025. Trend: 2023 $752 · 2024 $851 · 2025 $2,053
Food & beverage: $2,053
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 10 | $652 |
| ABBVIE INC. | 4 | $368 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $248 |
| Phathom Pharmaceuticals, Inc. | 2 | $240 |
| Ipsen Biopharmaceuticals, Inc | 1 | $150 |
| Janssen Biotech, Inc. | 1 | $150 |
| Ardelyx, Inc. | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $119 |
Products named: REZDIFFRA, RINVOQ, XIFAXAN, VOQUEZNA, IQIRVO, TREMFYA, IBSRELA, Livdelzi.
Industry payments across NJ — which companies pay providers there.
